My question likely won't even be seen now by the one that posed the question. About a dozen peats and repeats came in and quickly buried my post. Oh well, somethings don't really change
"What COULD the EMA be evaluating?" I am sitting down, trying to think intelligently what the answer to your question could be, but I'm drawing a blank. Perhaps years of actually reading this board is beginning to dull my focus. What is your theory regarding the amikacin application? Is it something new from somebody else?
This product if approved one day would be used to treat PAH, IPF, Severe asthma, and sarcoidosis - something that was frequently misdiagnosed on the tv show House. Zake got me thinking that there really hasn't been anything new to discuss on this board, and many are tired of reading about charts and percentage gains, and other nonsense.
On Insmed's latest 10Q they state that phase I results for INS1009 will be released at a medical meeting in the second half of 2016. My guess is that will be the International Vascular Biology meeting Oct. 30 thru Nov. 3 in Boston. 1 because it is titled a meeting as opposed to a conference and 2 because it's somewhat nearby in Boston.
Probably nobody really cares, but I just had an inkling to bring up something sort of new.
Zake, I don't care about his trades either, although it looks to me that the point of the post was that he really has no trades.... That said, there isn't much to say about Insmed right now except that it would be nice to see a full enrollment announcement before December, and phase I results from their PAH trial. I realize that all the comments to and about him don't make this message board that he has pretty much ruined any better, and I have been staying away because my personality makes it difficult for me not to respond to idiocy. I do have a call in to Susan Mesco to see if she can help me better understand one question I do have regarding any reports we might be expecting regarding the phase III trial. I still subscribe to Investors Village and I wish all decent contributors did also. Over on that board you can actually call, talk to a person, and they will monitor the board. More importantly, there is a monthly fee so multiple ID's would be costly. I realize that you own plenty of shares, but so do I and occasionally I will still point out his lies simply because sometimes there are new visitors here that should know the truth.
I saw an ad on television for a birth control device that names possible side effects. They were numerous, and included death. I find it incredible that a birth control device that actually names DEATH as a side effect is approved and on the market, but arikayce which in a real clinical trial cured 300% more patients than SOC alone, is still enrolling for IMO a not even necessary phase III trial. I say incredible, but believe that word could be substituted with criminal.....
Well, it would be even more concerning if stores were closing, and none were opening. I don't think the shares could be purchased anywhere near these levels if the company wasn't having some hiccups, but I was a buyer once again today based entirely on the premise that moves are being made to right the ship, and good news will lead to a huge percentage move with this one. PE getting involved in some fashion as some here have mentioned certainly would not surprise me
Well, I think that they can make any announcements during blackout periods...... They just can't buy or sell shares
There sure wasn't an announcement, I had to go to the Pie Five location site to make sure it opened. I can't say for sure, but my guess is that of all 90+ stores that have opened that was the first that had no PR.